ABSTRACT
This UK study revealed the benefits of introducing gluten at age 4 months.
Subject(s)
Celiac Disease , Glutens , Breast Feeding , Celiac Disease/prevention & control , Female , Glutens/adverse effects , Humans , InfantABSTRACT
Acute diarrheal disease accounts for 179 million outpatient visits annually in the United States. Diarrhea can be categorized as inflammatory or noninflammatory, and both types have infectious and noninfectious causes. Infectious noninflammatory diarrhea is often viral in etiology and is the most common presentation; however, bacterial causes are also common and may be related to travel or foodborne illness. History for patients with acute diarrhea should include onset and frequency of symptoms, stool character, a focused review of systems including fever and other symptoms, and evaluation of exposures and risk factors. The physical examination should include evaluation for signs of dehydration, sepsis, or potential surgical processes. Most episodes of acute diarrhea in countries with adequate food and water sanitation are uncomplicated and self-limited, requiring only an initial evaluation and supportive treatment. Additional diagnostic evaluation and management may be warranted when diarrhea is bloody or mucoid or when risk factors are present, including immunocompromise or recent hospitalization. Unless an outbreak is suspected, molecular studies are preferred over traditional stool cultures. In all cases, management begins with replacing water, electrolytes, and nutrients. Oral rehydration is preferred; however, signs of severe dehydration or sepsis warrant intravenous rehydration. Antidiarrheal agents can be symptomatic therapy for acute watery diarrhea and can help decrease inappropriate antibiotic use. Empiric antibiotics are rarely warranted, except in sepsis and some cases of travelers' or inflammatory diarrhea. Targeted antibiotic therapy may be appropriate following microbiologic stool assessment. Hand hygiene, personal protective equipment, and food and water safety measures are integral to preventing infectious diarrheal illnesses.
Subject(s)
Dehydration , Sepsis , Acute Disease , Adult , Anti-Bacterial Agents/therapeutic use , Antidiarrheals/therapeutic use , Dehydration/diagnosis , Dehydration/etiology , Dehydration/therapy , Diarrhea/diagnosis , Diarrhea/etiology , Diarrhea/therapy , Fluid Therapy , Humans , Sepsis/complications , WaterABSTRACT
Approximately one-half of patients with alcohol use disorder who abruptly stop or reduce their alcohol use will develop signs or symptoms of alcohol withdrawal syndrome. The syndrome is due to overactivity of the central and autonomic nervous systems, leading to tremors, insomnia, nausea and vomiting, hallucinations, anxiety, and agitation. If untreated or inadequately treated, withdrawal can progress to generalized tonic-clonic seizures, delirium tremens, and death. The three-question Alcohol Use Disorders Identification Test-Consumption and the Single Alcohol Screening Question instrument have the best accuracy for assessing unhealthy alcohol use in adults 18 years and older. Two commonly used tools to assess withdrawal symptoms are the Clinical Institute Withdrawal Assessment for Alcohol Scale, Revised, and the Short Alcohol Withdrawal Scale. Patients with mild to moderate withdrawal symptoms without additional risk factors for developing severe or complicated withdrawal should be treated as outpatients when possible. Ambulatory withdrawal treatment should include supportive care and pharmacotherapy as appropriate. Mild symptoms can be treated with carbamazepine or gabapentin. Benzodiazepines are first-line therapy for moderate to severe symptoms, with carbamazepine and gabapentin as potential adjunctive or alternative therapies. Physicians should monitor outpatients with alcohol withdrawal syndrome daily for up to five days after their last drink to verify symptom improvement and to evaluate the need for additional treatment. Primary care physicians should offer to initiate long-term treatment for alcohol use disorder, including pharmacotherapy, in addition to withdrawal management.
Subject(s)
Alcoholism/complications , Ambulatory Care/methods , Substance Withdrawal Syndrome/complications , Alcoholism/etiology , Anticonvulsants/therapeutic use , Benzodiazepines/therapeutic use , Carbamazepine/therapeutic use , Disease Management , Humans , Substance Withdrawal Syndrome/etiologyABSTRACT
Obtain greater accuracy in blood pressure measurement with an automated office device.
Subject(s)
Automation/statistics & numerical data , Blood Pressure Determination/instrumentation , Blood Pressure Determination/methods , Blood Pressure Monitoring, Ambulatory/instrumentation , Blood Pressure Monitoring, Ambulatory/methods , Hypertension/diagnosis , Sphygmomanometers/statistics & numerical data , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , United StatesSubject(s)
Decision Support Techniques , Syncope/diagnosis , Adult , Canada , Emergency Service, Hospital , Humans , Syncope/etiologyABSTRACT
The first meta-analysis to focus on viscous dietary fiber in T2D suggests a potential role for this supplement in improving glycemic control.